BOUNDLESS BIO INC (BOLD) Stock Income Statement
NASDAQ:BOLD • US10170A1007
Current stock price
1.58 USD
-0.05 (-3.07%)
At close:
1.5518 USD
-0.03 (-1.78%)
Pre-Market:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 63.55M | 73.27M | 54.80M | 46.47M | 25.30M | |||
| Research and Development | 44.84M | 55.27M | 42.64M | 37.16M | 19.28M | |||
| Selling, General, and Administrative Expenses | 18.71M | 18.00M | 12.16M | 9.31M | 6.02M | |||
| Operating Income | -63.55M | -73.27M | -54.80M | -46.47M | -25.30M | |||
| Interest Income/Expense | 5.36M | 7.89M | 5.28M | 668.00K | 96.00K | |||
| Other Income/Expense | -2.00K | 12.00K | 80.00K | -100.00K | -5.00K | |||
| Income Before Taxes | -58.20M | -65.36M | -49.43M | -45.90M | -25.21M | |||
| Net Income | -58.20M | -65.36M | -49.43M | -45.90M | -25.21M | |||
| EBITDA | -62.30M | -72.18M | -53.84M | -45.53M | -24.62M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.60 | -3.85 | -2.22 | -2.06 | -1.13 | |||
| Non GAAP EPS | -2.61 | -14.52 | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD